SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/23/22 Commonwealth Income & Growth … VI 10-Q 6/30/22 47:1.8M Blueprint/FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 383K 2: EX-31.1 Certification -- §302 - SOA'02 HTML 19K 3: EX-31.2 Certification -- §302 - SOA'02 HTML 19K 4: EX-32.1 Certification -- §906 - SOA'02 HTML 15K 5: EX-32.2 Certification -- §906 - SOA'02 HTML 15K 11: R1 Cover HTML 64K 12: R2 Condensed Balance Sheets HTML 86K 13: R3 Condensed Balance Sheets (Parenthetical) HTML 25K 14: R4 Condensed Statements of Operations (Unaudited) HTML 75K 15: R5 Condensed Statement of Partners' Equity HTML 42K (Unaudited) 16: R6 Condensed Statements of Cash Flow (Unaudited) HTML 30K 17: R7 Business HTML 21K 18: R8 Summary of Significant Accounting Policies HTML 28K 19: R9 Information Technology Medical Technology HTML 26K Telecommunications Technology Inventory Management Equipment (Equipment) 20: R10 Related Party Transactions HTML 34K 21: R11 Notes Payable HTML 29K 22: R12 Supplemental Cash Flow Information HTML 20K 23: R13 Commitments and Contingencies HTML 27K 24: R14 Summary of Significant Accounting Policies HTML 33K (Policies) 25: R15 Summary of Significant Accounting Policies HTML 19K (Tables) 26: R16 Information Technology Medical Technology HTML 21K Telecommunications Technology Inventory Management Equipment (Tables) 27: R17 Related Party Transactions (Tables) HTML 32K 28: R18 Notes Payable (Tables) HTML 26K 29: R19 Supplemental Cash Flow Information (Tables) HTML 19K 30: R20 Business (Details Narrative) HTML 27K 31: R21 Summary of Significant Accounting Policies HTML 20K (Details) 32: R22 Summary of Significant Accounting Policies HTML 19K (Details Narrative) 33: R23 Information Technology Medical Technology HTML 27K Telecommunications Technology Inventory Management Equipment and other BusinessEssential Capital Equipment (Equipment) (Details) 34: R24 Information Technology Medical Technology HTML 25K Telecommunications Technology Inventory Management Equipment and other BusinessEssential Capital Equipment (Equipment) (Details Narrative) 35: R25 Related Party Transactions (Details) HTML 21K 36: R26 Related Party Transactions (Details Narrative) HTML 18K 37: R27 Notes Payable (Details) HTML 26K 38: R28 Notes Payable (Details 1) HTML 26K 39: R29 Notes Payable (Details Narrative) HTML 16K 40: R30 Supplemental Cash Flow Information (Details) HTML 17K 41: R31 Supplemental Cash Flow Information (Details HTML 17K Narrative) 42: R32 Commitments and Contingencies (Details Narrative) HTML 37K 45: XML IDEA XML File -- Filing Summary XML 79K 43: XML XBRL Instance -- cigf_10q_htm XML 305K 44: EXCEL IDEA Workbook of Financial Reports XLSX 61K 8: EX-101.CAL XBRL Calculations -- cigf6-20220630_cal XML 81K 10: EX-101.DEF XBRL Definitions -- cigf6-20220630_def XML 95K 7: EX-101.LAB XBRL Labels -- cigf6-20220630_lab XML 326K 9: EX-101.PRE XBRL Presentations -- cigf6-20220630_pre XML 249K 6: EX-101.SCH XBRL Schema -- cigf6-20220630 XSD 81K 46: JSON XBRL Instance as JSON Data -- MetaLinks 157± 211K 47: ZIP XBRL Zipped Folder -- 0001654954-22-011705-xbrl Zip 93K
EXHIBIT 31.2
31.2 RULE 15d-14(a) CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
I, Kimberly A. Springsteen-Abbott, certify that:
1. | I have reviewed this quarterly report on Form 10-Q of Commonwealth Income & Growth Fund VI (the Registrant); |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. |
The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have: |
| (a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
|
|
| (b) | Designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
|
|
| (c) | Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
|
| (d) | Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
5. | The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): |
| (a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
|
|
|
| (b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
|
|
|
| |
Principal Financial Officer |
|
|
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 8/23/22 | |||
For Period end: | 6/30/22 | NT 10-Q | ||
List all Filings |